FONR FONAR Corporation
Healthcare$18.91+0.08%ClosedMarket Cap: $116.7M
As of 2026-05-26
Valuation
P/E (TTM)
15.26
PEG
—
P/B
0.65
P/S
1.11
EV/EBITDA
7.25
DCF Value
$24.78
FCF Yield
3.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
40.3%
Operating Margin
9.0%
Net Margin
6.4%
ROE
3.8%
ROA
3.1%
ROIC
3.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $26.5M | 42.5% | $2.4M | $1.6M | $— | — |
| Q2 null | $25.5M | 37.9% | $3.0M | $2.1M | $— | — |
| Q1 null | $26.0M | 40.1% | $3.2M | $2.3M | $— | — |
| Q4 null | $27.3M | 40.4% | $894.8K | $729.3K | $— | — |
| FY null | $104.4M | 41.1% | $11.6M | $8.3M | $— | — |
| Q3 null | $27.2M | 44.5% | $3.7M | $2.5M | $— | — |
| Q2 null | $24.9M | 39.0% | $2.4M | $2.0M | $— | — |
| Q1 null | $25.0M | 40.2% | $4.6M | $3.1M | $— | — |
| Q4 null | $25.9M | 40.8% | $1.3M | $830.4K | $— | — |
| FY null | $102.9M | 43.9% | $16.5M | $10.6M | $— | — |
| Q3 null | $25.7M | 45.7% | $3.7M | $1.9M | $— | — |
| Q2 2024 | $25.4M | 42.9% | $4.9M | $3.8M | $0.54 | — |